- cross-posted to:
- usnews
- cross-posted to:
- usnews
The move by the biotech company, which in 2019 took similar measures in the ethnic region of Xinjiang, came at a time of concerns on the Capitol Hill over Beijing’s human rights record.
You must log in or register to comment.